Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680549 · ClinicalTrials.gov registry record · Phase 4
Pain Control With Total Knee Replacement
A Phase 4 study of Postoperative Pain, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01680549 is a Phase 4 study of Postoperative Pain that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 50 participants, below the 231-participant average among 63 other Postoperative Pain trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01680549, a Phase 4 study of Postoperative Pain, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to study the effects of gabapentin on pain control in the perioperative and post-operative period of total knee arthroplasty.
Conditions Studied
Interventions
- DRUG Gabapentin
Study Locations (1)
Texas
- TTUHSC Orthopaedic Surgery MS 9436 - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01680549
The ClinicalTrials.gov registry entry for NCT01680549 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 63 other Postoperative Pain trials with a reported enrollment target (78% lower). The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Gabapentin is the first listed.
NCT01680549 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01680549 about?
NCT01680549 is a clinical study titled "Pain Control With Total Knee Replacement". The purpose of this project is to study the effects of gabapentin on pain control in the perioperative and post-operative period of total knee arthroplasty.
What is the current status of trial NCT01680549?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-09. Estimated completion is 2016-02.
What conditions does trial NCT01680549 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT01680549?
The interventions under investigation include: Gabapentin (DRUG).
Who is sponsoring clinical trial NCT01680549?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01680549 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Single-shot TAP Block vs Continuous TAP Block
COMPLETED · Phase 4
-
Intrathecal Morphine for Cesarean Delivery
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.